Saba NF - Search Results

1

Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Mody MD, et al. Among authors: saba nf. Lancet. 2021 Dec 18;398(10318):2289-2299. doi: 10.1016/S0140-6736(21)01550-6. Epub 2021 Sep 22. Lancet. 2021. PMID: 34562395 Review.

2

Retinoids as chemoprevention for head and neck cancer: where do we go from here?

Smith W, Saba N. Smith W, et al. Crit Rev Oncol Hematol. 2005 Aug;55(2):143-52. doi: 10.1016/j.critrevonc.2005.02.003. Crit Rev Oncol Hematol. 2005. PMID: 15886010 Review.

3

Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.

Saba NF, Khuri FR, Shin DM. Saba NF, et al. Oncology (Williston Park). 2006 Feb;20(2):153-61; discussion 162, 166, 169 passim. Oncology (Williston Park). 2006. PMID: 16562649 Review.

4

Moving toward bioadjuvant approaches to head and neck cancer prevention.

Saba NF, Hammond A, Shin DM, Khuri FR. Saba NF, et al. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5. doi: 10.1016/j.ijrobp.2007.05.041. Int J Radiat Oncol Biol Phys. 2007. PMID: 17848282 Review.

5

Targeting angiogenesis in head and neck cancer.

Saba NF, Shin DM, Khuri FR. Saba NF, et al. Curr Cancer Drug Targets. 2007 Nov;7(7):643-9. doi: 10.2174/156800907782418356. Curr Cancer Drug Targets. 2007. PMID: 18045069 Review.

6

Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.

Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z. Muller S, et al. Cancer. 2008 Jul 1;113(1):97-107. doi: 10.1002/cncr.23557. Cancer. 2008. PMID: 18473353 Free article.

7

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.

Saba NF, Wang X, Müller S, Tighiouart M, Cho K, Nie S, Chen Z, Shin DM. Saba NF, et al. Head Neck. 2009 Apr;31(4):475-81. doi: 10.1002/hed.21003. Head Neck. 2009. PMID: 19072997 Free PMC article.

8

Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.

Saba NF, Khuri FR. Saba NF, et al. Curr Opin Oncol. 2009 May;21(3):232-7. doi: 10.1097/cco.0b013e32832a56b3. Curr Opin Oncol. 2009. PMID: 19370807 Review.

9

Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation.

Lawson JD, Gaultney J, Saba N, Grist W, Davis L, Johnstone PA. Lawson JD, et al. Am J Otolaryngol. 2009 Jul-Aug;30(4):244-9. doi: 10.1016/j.amjoto.2008.06.010. Epub 2009 Feb 6. Am J Otolaryngol. 2009. PMID: 19563935

10

Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Saba NF, Choi M, Muller S, Shin HJ, Tighiouart M, Papadimitrakopoulou VA, El-Naggar AK, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Cancer Prev Res (Phila). 2009 Sep;2(9):823-9. doi: 10.1158/1940-6207.CAPR-09-0077. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737986 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page